{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:04:42Z","timestamp":1785571482171,"version":"3.56.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science andTechnology Cooperation Foundation of Health BioMed","award":["Grant No. 20200605"],"award-info":[{"award-number":["Grant No. 20200605"]}]},{"name":"Zhenjiang Science and Technology Plan (Social Development) Project","award":["SH2024015"],"award-info":[{"award-number":["SH2024015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11064-025-04422-x","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:48:53Z","timestamp":1748594933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protective Effect of FABP5 Against 6-OHDA Induced Parkinson\u2019s Disease Via PPAR\u03b3\/SIRT1\/PGC-1\u03b1 Signaling Pathway"],"prefix":"10.1007","volume":"50","author":[{"given":"Yinying","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abid","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yancheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijuan","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-984X","authenticated-orcid":false,"given":"Jiabo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"4422_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/biom11040612","volume":"11","author":"FC Church","year":"2021","unstructured":"Church FC (2021) Treatment options for motor and Non-Motor symptoms of Parkinson\u2019s disease. Biomolecules 11:612. https:\/\/doi.org\/10.3390\/biom11040612","journal-title":"Biomolecules"},{"issue":"11","key":"4422_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"GBDNDC Group","year":"2017","unstructured":"Group GBDNDC (2017) Global, regional, and National burden of neurological disorders during 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol 16(11):877\u2013897. https:\/\/doi.org\/10.1016\/S1474-4422(17)30299-5","journal-title":"Lancet Neurol"},{"issue":"7","key":"4422_CR3","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/s2666-7568(24)00094-1","volume":"5","author":"J Zhu","year":"2024","unstructured":"Zhu J, Cui Y, Zhang J, Yan R, Su D, Zhao D, Wang A, Feng T (2024) Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev 5(7):e464. https:\/\/doi.org\/10.1016\/s2666-7568(24)00094-1","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"4422_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Therapy 8(1):73. https:\/\/doi.org\/10.1038\/s41392-023-01353-3","journal-title":"Signal Transduct Target Therapy"},{"key":"4422_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","volume":"403","author":"T Foltynie","year":"2024","unstructured":"Foltynie T, Bruno V, Fox S, Kuhn AA, Lindop F, Lees AJ (2024) Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet 403:305\u2013324. https:\/\/doi.org\/10.1016\/S0140-6736(23)01429-0","journal-title":"Lancet"},{"key":"4422_CR6","doi-asserted-by":"publisher","unstructured":"Obeso JA, Olanow CW, Nutt JG (2000) Levodopa motor complications in Parkinson\u2019s disease. Trends Neurosci 23(10 Suppl). https:\/\/doi.org\/10.1016\/s1471-1931(00)00031-8","DOI":"10.1016\/s1471-1931(00)00031-8"},{"key":"4422_CR7","doi-asserted-by":"publisher","unstructured":"Poletti M, Frosini D, Fau - Pagni C, Pagni C, Fau - Baldacci F, Baldacci F, Fau - Nicoletti V, Nicoletti V, Fau - Tognoni G, Tognoni G, Fau - Lucetti C, Lucetti C Fau - Del Dotto P, Del Dotto P Fau - Ceravolo R, Ceravolo R, Fau - Bonuccelli U, Bonuccelli U (2012) Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson\u2019s disease. Journal of neurology, neurosurgery, and psychiatry 83(6):601\u2013606.https:\/\/doi.org\/10.1136\/jnnp-2011-301874","DOI":"10.1136\/jnnp-2011-301874"},{"issue":"7","key":"4422_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"4422_CR9","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.arr.2022.101812","volume":"84","author":"JC Claudino Dos Santos","year":"2023","unstructured":"Claudino Dos Santos JC, Lima MPP, Brito GAC, Viana GSB (2023) Role of enteric glia and microbiota-gut-brain axis in Parkinson disease pathogenesis. Ageing Res Rev 84:101812. https:\/\/doi.org\/10.1016\/j.arr.2022.101812","journal-title":"Ageing Res Rev"},{"issue":"5","key":"4422_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"issue":"9","key":"4422_CR11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi ML, Chappard A, Singh BP, Maclachlan C, Rodrigues M, Fedotova EI, Berezhnov AV, De S, Peddie CJ, Athauda D, Virdi GS, Zhang W, Evans JR, Wernick AI, Zanjani ZS, Angelova PR, Esteras N, Vinokurov AY, Morris K, Jeacock K, Tosatto L, Little D, Gissen P, Clarke DJ, Kunath T, Collinson L, Klenerman D, Abramov AY, Horrocks MH, Gandhi S (2022) Pathological structural conversion of alpha-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci 25(9):1134\u20131148. https:\/\/doi.org\/10.1038\/s41593-022-01140-3","journal-title":"Nat Neurosci"},{"issue":"7886","key":"4422_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"PA-O Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez PA-O, Zampese EA-O, Stout KA, Guzman JN, Ilijic E, Yang BA-O, Tkatch T, Stavarache MA, Wokosin DL, Gao LA-O, Kaplitt MG, L\u00f3pez-Barneo J, Schumacker PA-O, Surmeier DA-O (2021) Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599(7886):650\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04059-0","journal-title":"Nature"},{"issue":"6","key":"4422_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: A review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"4422_CR14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet (London England) 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet (London England)"},{"issue":"4","key":"4422_CR15","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","volume":"102","author":"MA Eldeeb","year":"2022","unstructured":"Eldeeb MA, Thomas RA, Ragheb MA, Fallahi A, Fon EA (2022) Mitochondrial quality control in health and in Parkinson\u2019s disease. Physiol Rev 102(4):1721\u20131755. https:\/\/doi.org\/10.1152\/physrev.00041.2021","journal-title":"Physiol Rev"},{"key":"4422_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/brain\/awad364","volume":"147","author":"T Payne","year":"2024","unstructured":"Payne T, Burgess T, Bradley S, Roscoe S, Sassani M, Dunning MJ, Hernandez D, Scholz S, McNeill A, Taylor R, Su L, Wilkinson I, Jenkins T, Mortiboys H, Bandmann O (2024) Multimodal assessment of mitochondrial function in Parkinson\u2019s disease. Brain 147:267\u2013280. https:\/\/doi.org\/10.1093\/brain\/awad364","journal-title":"Brain"},{"issue":"2","key":"4422_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","volume":"31","author":"CS Field","year":"2020","unstructured":"Field CS, Baixauli F, Kyle RL, Puleston DJ, Cameron AM, Sanin DE, Hippen KL, Loschi M, Thangavelu G, Corrado M, Edwards-Hicks J, Grzes KM, Pearce EJ, Blazar BR, Pearce EL (2020) Mitochondrial integrity regulated by lipid metabolism is a Cell-Intrinsic checkpoint for Treg suppressive function. Cell Metabol 31(2):422\u2013437. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.021","journal-title":"Cell Metabol"},{"issue":"4","key":"4422_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.xphs.2017.11.024","volume":"107","author":"GS Lee","year":"2018","unstructured":"Lee GS, Pan Y, Scanlon MJ, Porter CJH, Nicolazzo JA (2018) Fatty Acid-Binding protein 5 mediates the uptake of fatty acids, but not drugs, into human brain endothelial cells. J Pharm Sci 107(4):1185\u20131193. https:\/\/doi.org\/10.1016\/j.xphs.2017.11.024","journal-title":"J Pharm Sci"},{"key":"4422_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.857919","author":"B Xu","year":"2022","unstructured":"Xu B, Chen L, Zhan Y, Marquez KNS, Zhuo L, Qi S, Zhu J, He Y, Chen X, Zhang H, Shen Y, Chen G, Gu J, Guo Y, Liu S, Xie T (2022) The biological functions and regulatory mechanisms of fatty acid binding protein 5 in various diseases. Front Cell Dev Biology. https:\/\/doi.org\/10.3389\/fcell.2022.857919","journal-title":"Front Cell Dev Biology"},{"key":"4422_CR20","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1471-4159.2008.05507.x","volume":"106","author":"JW Liu","year":"2008","unstructured":"Liu JW, Almaguel FG, Bu L, De Leon DD, De Leon M (2008) Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids. J Neurochem 106:2015\u20132029. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05507.x","journal-title":"J Neurochem"},{"key":"4422_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jnc.12934","volume":"132","author":"JW Liu","year":"2015","unstructured":"Liu JW, Montero M, Bu L, De Leon M (2015) Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injury. J Neurochem 132:85\u201398. https:\/\/doi.org\/10.1111\/jnc.12934","journal-title":"J Neurochem"},{"issue":"50","key":"4422_CR22","doi-asserted-by":"publisher","first-page":"42195","DOI":"10.1074\/jbc.M112.410381","volume":"287","author":"S Yu","year":"2012","unstructured":"Yu S, Levi L, Siegel R, Noy N (2012) Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta). J Biol Chem 287(50):42195\u201342205. https:\/\/doi.org\/10.1074\/jbc.M112.410381","journal-title":"J Biol Chem"},{"issue":"11","key":"4422_CR23","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1158\/0008-5472.CAN-13-2689","volume":"74","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Sun Y, Rao E, Yan F, Li Q, Zhang Y, Silverstein KA, Liu S, Sauter E, Cleary MP, Li B (2014) Fatty acid-binding protein E-FABP restricts tumor growth by promoting IFN-beta responses in tumor-associated macrophages. Cancer Res 74(11):2998. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2689","journal-title":"Cancer Res"},{"issue":"6","key":"4422_CR24","doi-asserted-by":"publisher","first-page":"e0300168","DOI":"10.1371\/journal.pone.0300168","volume":"19","author":"A Soto-Avellaneda","year":"2024","unstructured":"Soto-Avellaneda A, Oxford AE, Halla F, Vasquez P, Oe E, Pugel AD, Schoenfeld AM, Tillman MC, Cuevas A, Ortlund EA, Morrison BE (2024) FABP5-binding lipids regulate autophagy in differentiated SH-SY5Y cells. PLoS ONE 19(6):e0300168. https:\/\/doi.org\/10.1371\/journal.pone.0300168","journal-title":"PLoS ONE"},{"issue":"2","key":"4422_CR25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1039\/c8fo01713a","volume":"10","author":"X Huang","year":"2019","unstructured":"Huang X, Zhen J, Dong S, Zhang H, Van Halm-Lutterodt N, Yuan L (2019) DHA and vitamin E antagonized the Abeta(25\u201335)-mediated neuron oxidative damage through activation of Nrf2 signaling pathways and regulation of CD36, SRB1 and FABP5 expression in PC12 cells. Food Funct 10(2):1049\u20131061. https:\/\/doi.org\/10.1039\/c8fo01713a","journal-title":"Food Funct"},{"issue":"46","key":"4422_CR26","doi-asserted-by":"publisher","first-page":"11755","DOI":"10.1523\/JNEUROSCI.1583-16.2016","volume":"36","author":"Y Pan","year":"2016","unstructured":"Pan Y, Short JL, Choy KH, Zeng AX, Marriott PJ, Owada Y, Scanlon MJ, Porter CJ, Nicolazzo JA (2016) Fatty acid-Binding protein 5 at the Blood-Brain barrier regulates endogenous brain docosahexaenoic acid levels and cognitive function. J Neuroscience: Official J Soc Neurosci 36(46):11755\u201311767. https:\/\/doi.org\/10.1523\/JNEUROSCI.1583-16.2016","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"key":"4422_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature21379","volume":"543","author":"Y Pan","year":"2017","unstructured":"Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O\u2019Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA, Kupper TS (2017) Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543:252\u2013256. https:\/\/doi.org\/10.1038\/nature21379","journal-title":"Nature"},{"key":"4422_CR28","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.3390\/nu16234025","volume":"16","author":"AM Duran","year":"2024","unstructured":"Duran AM, Zamora F, De Leon M (2024) Dietary docosahexaenoic Acid-Rich supplementation decreases neurotoxic lipid mediators in participants with type 2 diabetes and neuropathic pain. Nutrients 16:4025. https:\/\/doi.org\/10.3390\/nu16234025","journal-title":"Nutrients"},{"issue":"6","key":"4422_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00018-023-04807-7","volume":"80","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ding L, Zhang M, Zheng S, Ma R, Gong J, Mao H, Xu H, Xu P, Zhang Y (2023) Dietary intake of alpha-ketoglutarate ameliorates alpha-synuclein pathology in mouse models of Parkinson\u2019s disease. Cell Mol Life Sci 80(6):155. https:\/\/doi.org\/10.1007\/s00018-023-04807-7","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"4422_CR30","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1021\/acs.molpharmaceut.5b00580","volume":"12","author":"Y Pan","year":"2015","unstructured":"Pan Y, Scanlon MJ, Owada Y, Yamamoto Y, Porter CJ, Nicolazzo JA (2015) Fatty acid-Binding protein 5 facilitates the Blood-Brain barrier transport of docosahexaenoic acid. Mol Pharm 12(12):4375\u20134385. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00580","journal-title":"Mol Pharm"},{"issue":"6","key":"4422_CR31","doi-asserted-by":"publisher","first-page":"e13190","DOI":"10.1111\/bpa.13190","volume":"33","author":"JR Chong","year":"2023","unstructured":"Chong JR, Chai YL, Xing H, Herr DR, Wenk MR, Francis PT, Ballard C, Aarsland D, Silver DL, Chen CP, Cazenave-Gassiot A, Lai MKP (2023) Decreased DHA-containing phospholipids in the neocortex of dementia with lewy bodies are associated with soluble Abeta(42), phosphorylated alpha-synuclein, and synaptopathology. Brain Pathol 33(6):e13190. https:\/\/doi.org\/10.1111\/bpa.13190","journal-title":"Brain Pathol"},{"issue":"2","key":"4422_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/brainsci8020032","volume":"8","author":"A Lahiani","year":"2018","unstructured":"Lahiani A, Brand-Yavin A, Yavin EA-O, Lazarovici P (2018) Neuroprotective effects of bioactive compounds and MAPK pathway modulation in Ischemia-Stressed PC12 pheochromocytoma cells. LID\u2013\u200910.3390\/brainsci8020032 [doi] LID\u2013\u200932. Brain Sci 8(2):32. https:\/\/doi.org\/10.3390\/brainsci8020032","journal-title":"Brain Sci"},{"issue":"7","key":"4422_CR33","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/ijms21072464","volume":"21","author":"SJ Chia","year":"2020","unstructured":"Chia SJ, Tan EK, Chao YX (2020) Historical perspective: models of Parkinson\u2019s disease. Int J Mol Sci 21(7):2464. https:\/\/doi.org\/10.3390\/ijms21072464","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4422_CR34","doi-asserted-by":"publisher","first-page":"e30568","DOI":"10.1002\/jcb.30568","volume":"125","author":"GA-O Yang","year":"2024","unstructured":"Yang GA-O, Liu K, Ma S, Qi P (2024) PPAR\u03b3 Inhibition promotes osteogenic differentiation of bone marrow mesenchymal stem cells and fracture healing. J Cell Biochem 125(6):e30568. https:\/\/doi.org\/10.1002\/jcb.30568","journal-title":"J Cell Biochem"},{"issue":"12","key":"4422_CR35","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/molecules25122907","volume":"25","author":"YA-O Chen","year":"2020","unstructured":"Chen YA-O, Wu SA-O, Gao JM, Liao ZY, Tseng YT, F\u00fcl\u00f6p FA-O, Chang FA-O, Lo YA-OX (2020) The antioxidant, Anti-Inflammatory, and neuroprotective properties of the synthetic chalcone derivative AN07. LID\u2013\u200910.3390\/molecules25122907 [doi] LID\u2013\u20092907. Molecules 25(12):2907. https:\/\/doi.org\/10.3390\/molecules25122907","journal-title":"Molecules"},{"key":"4422_CR36","doi-asserted-by":"publisher","first-page":"147978","DOI":"10.1016\/j.brainres.2022.147978","volume":"1790","author":"W Ni","year":"2022","unstructured":"Ni W, Zhou J, Ling Y, Lu X, Niu D, Zeng Y, Qiu Y, Si Y, Wang J, Zhang W, Wang Z, Hu J (2022) Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson\u2019s disease model. Brain Res 1790:147978. https:\/\/doi.org\/10.1016\/j.brainres.2022.147978","journal-title":"Brain Res"},{"key":"4422_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303\u2013317. https:\/\/doi.org\/10.1006\/exnr.2002.7891","journal-title":"Exp Neurol"},{"issue":"1","key":"4422_CR38","doi-asserted-by":"publisher","first-page":"19478","DOI":"10.1038\/s41598-023-46576-0","volume":"13","author":"A Slezia","year":"2023","unstructured":"Slezia A, Hegedus P, Rusina E, Lengyel K, Solari N, Kaszas A, Balazsfi D, Botzanowski B, Acerbo E, Missey F, Williamson A, Hangya B (2023) Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson\u2019s disease. Sci Rep 13(1):19478. https:\/\/doi.org\/10.1038\/s41598-023-46576-0","journal-title":"Sci Rep"},{"key":"4422_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"HX Chen","year":"2020","unstructured":"Chen HX, Liang FC, Gu P, Xu BL, Xu HJ, Wang WT, Hou JY, Xie DX, Chai XQ, An SJ (2020) Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis 11:288. https:\/\/doi.org\/10.1038\/s41419-020-2473-5","journal-title":"Cell Death Dis"},{"key":"4422_CR40","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.3390\/ijms23126713","volume":"23","author":"A Wojtas","year":"2022","unstructured":"Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maslanka I, Herian M, Mackowiak M, Golembiowska K (2022) Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior. Int J Mol Sci 23:6713. https:\/\/doi.org\/10.3390\/ijms23126713","journal-title":"Int J Mol Sci"},{"key":"4422_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fphar.2020.00091","volume":"11","author":"S Boccella","year":"2020","unstructured":"Boccella S, Iannotta M, Cristiano C, Iannotti FA, Bello FD, Guida F, Belardo C, Infantino R, Ricciardi F, Giannella M, Calignano A, Di Marzo V, Maione S, Luongo L (2020) Treatment with 2-Pentadecyl-2-Oxazoline restores mild traumatic brain Injury-Induced sensorial and neuropsychiatric dysfunctions. Front Pharmacol 11:91. https:\/\/doi.org\/10.3389\/fphar.2020.00091","journal-title":"Front Pharmacol"},{"key":"4422_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.euroneuro.2023.08.496","volume":"77","author":"MJ Primo","year":"2023","unstructured":"Primo MJ, Fonseca-Rodrigues D, Almeida A, Teixeira PM, Pinto-Ribeiro F (2023) Sucrose preference test: A systematic review of protocols for the assessment of anhedonia in rodents. Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol 77:80\u201392. https:\/\/doi.org\/10.1016\/j.euroneuro.2023.08.496","journal-title":"Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol"},{"key":"4422_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2015.07.005","volume":"50","author":"PL Gambus","year":"2015","unstructured":"Gambus PL, Troconiz IF, Feng X, Gimenez-Mila M, Mellado R, Degos V, Vacas S, Maze M (2015) Relation between acute and long-term cognitive decline after surgery: influence of metabolic syndrome. Brain Behav Immun 50:203\u2013208. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.005","journal-title":"Brain Behav Immun"},{"issue":"8","key":"4422_CR44","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1515\/revneuro-2020-0149","volume":"32","author":"C Thornberry","year":"2021","unstructured":"Thornberry C, Cimadevilla JM, Commins S (2021) Virtual Morris water maze: opportunities and challenges. Rev Neurosci 32(8):887\u2013903. https:\/\/doi.org\/10.1515\/revneuro-2020-0149","journal-title":"Rev Neurosci"},{"key":"4422_CR45","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1021\/acs.molpharmaceut.5b00580","volume":"12","author":"Y Pan","year":"2015","unstructured":"Pan Y, Scanlon MJ, Owada Y, Yamamoto Y, Porter CJ, Nicolazzo JA (2015) Fatty acid-Binding protein 5 facilitates the Blood-Brain barrier transport of docosahexaenoic acid. Mol Pharm 12:4375\u20134385. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00580","journal-title":"Mol Pharm"},{"key":"4422_CR46","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1161\/ATVBAHA.113.301588","volume":"33","author":"T Iso","year":"2013","unstructured":"Iso T, Maeda K, Hanaoka H, Suga T, Goto K, Syamsunarno MR, Hishiki T, Nagahata Y, Matsui H, Arai M, Yamaguchi A, Abumrad NA, Sano M, Suematsu M, Endo K, Hotamisligil GS, Kurabayashi M (2013) Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle. Arterioscler Thromb Vasc Biol 33:2549\u20132557. https:\/\/doi.org\/10.1161\/ATVBAHA.113.301588","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4422_CR47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/jid.2010.342","volume":"131","author":"E Ogawa","year":"2011","unstructured":"Ogawa E, Owada Y, Ikawa S, Adachi Y, Egawa T, Nemoto K, Suzuki K, Hishinuma T, Kawashima H, Kondo H, Muto M, Aiba S, Okuyama R (2011) Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-mediated activation of the NF-kappaB signaling pathway. J Invest Dermatol 131:604\u2013612. https:\/\/doi.org\/10.1038\/jid.2010.342","journal-title":"J Invest Dermatol"},{"key":"4422_CR48","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.7150\/ijbs.85285","volume":"19","author":"M Ye","year":"2023","unstructured":"Ye M, Hu C, Chen T, Yu P, Chen J, Lu F, Xu L, Zhong Y, Yan L, Kan J, Bai J, Li X, Tian Y, Tang Q (2023) FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression. Int J Mol Sci 19:3115\u20133127. https:\/\/doi.org\/10.7150\/ijbs.85285","journal-title":"Int J Mol Sci"},{"key":"4422_CR49","doi-asserted-by":"publisher","unstructured":"Penman SL, Roeder NM, Berthold EC, Senetra AS, Marion M, Richardson BJ, White O, Fearby NL, McCurdy CR, Hamilton J, Sharma A, Thanos PK (2023) FABP5 is important for cognitive function and is an important regulator of the physiological effects and pharmacokinetics of acute \u22069 tetrahydrocannabinol inhalation in mice. Pharmacol Biochem Behav 231. https:\/\/doi.org\/10.1016\/j.pbb.2023.173633","DOI":"10.1016\/j.pbb.2023.173633"},{"issue":"1","key":"4422_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s42003-024-06063-2","volume":"7","author":"W Lai","year":"2024","unstructured":"Lai W, Yu L, Deng Y (2024) PPARgamma alleviates preeclampsia development by regulating lipid metabolism and ferroptosis. Commun Biology 7(1):429. https:\/\/doi.org\/10.1038\/s42003-024-06063-2","journal-title":"Commun Biology"},{"key":"4422_CR51","doi-asserted-by":"publisher","first-page":"117438","DOI":"10.1016\/j.jep.2023.117438","volume":"321","author":"X Bai","year":"2024","unstructured":"Bai X, Zheng E, Tong L, Liu Y, Li X, Yang H, Jiang J, Chang Z, Yang H (2024) Angong Niuhuang Wan inhibit ferroptosis on ischemic and hemorrhagic stroke by activating PPARgamma\/AKT\/GPX4 pathway. J Ethnopharmacol 321:117438. https:\/\/doi.org\/10.1016\/j.jep.2023.117438","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"4422_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","volume":"45","author":"C Titus","year":"2024","unstructured":"Titus C, Hoque MT, Bendayan R (2024) PPAR agonists for the treatment of neuroinflammatory diseases. Trends Pharmacol Sci 45(1):9\u201323. https:\/\/doi.org\/10.1016\/j.tips.2023.11.004","journal-title":"Trends Pharmacol Sci"},{"key":"4422_CR53","doi-asserted-by":"publisher","first-page":"107228","DOI":"10.1016\/j.phrs.2024.107228","volume":"205","author":"W Hong","year":"2024","unstructured":"Hong W, Zeng X, Wang H, Tan X, Tian Y, Hu H, Ashrafizadeh M, Sethi G, Huang H, Duan C (2024) PGC-1alpha loss promotes mitochondrial protein lactylation in acetaminophen-induced liver injury via the LDHB-lactate axis. Pharmacol Res 205:107228. https:\/\/doi.org\/10.1016\/j.phrs.2024.107228","journal-title":"Pharmacol Res"},{"key":"4422_CR54","doi-asserted-by":"publisher","first-page":"101684","DOI":"10.1016\/j.xcrm.2024.101684","volume":"5","author":"B Lian","year":"2024","unstructured":"Lian B, Zhang J, Yin X, Wang J, Li L, Ju Q, Wang Y, Jiang Y, Liu X, Chen Y, Tang X, Sun C (2024) SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and Inhibition of PKM2. Cell Rep Med 5:101684. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101684","journal-title":"Cell Rep Med"},{"issue":"5","key":"4422_CR55","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2013.03.016","volume":"17","author":"R Wang","year":"2013","unstructured":"Wang R, Li JJ, Diao S, Kwak YD, Liu L, Zhi L, Bueler H, Bhat NR, Williams RW, Park EA, Liao FF (2013) Metabolic stress modulates Alzheimer\u2019s beta-secretase gene transcription via SIRT1-PPARgamma-PGC-1 in neurons. Cell Metabol 17(5):685\u2013694. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.016","journal-title":"Cell Metabol"},{"key":"4422_CR56","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1007\/s11064-024-04203-y","volume":"49","author":"RL Younis","year":"2024","unstructured":"Younis RL, El-Gohary RM, Ghalwash AA, Hegab II, Ghabrial MM, Aboshanady AM, Mostafa RA, El-Azeem AHA, Farghal EE, Belal AAE, Khattab H (2024) Luteolin mitigates D-Galactose-Induced brain ageing in rats: SIRT1-Mediated neuroprotection. Neurochem Res 49:2803\u20132820. https:\/\/doi.org\/10.1007\/s11064-024-04203-y","journal-title":"Neurochem Res"},{"key":"4422_CR57","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/biomedicines9020110","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shinoda Y, Cheng A, Kawahata I, Fukunaga K (2021) Epidermal fatty Acid-Binding protein 5 (FABP5) involvement in Alpha-Synuclein-Induced mitochondrial injury under oxidative stress. Biomedicines 9:110. https:\/\/doi.org\/10.3390\/biomedicines9020110","journal-title":"Biomedicines"},{"key":"4422_CR58","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/biomedicines8120635","volume":"8","author":"A Cheng","year":"2020","unstructured":"Cheng A, Kawahata I, Fukunaga K (2020) Fatty acid binding protein 5 mediates cell death by psychosine exposure through mitochondrial macropores formation in oligodendrocytes. Biomedicines 8:635. https:\/\/doi.org\/10.3390\/biomedicines8120635","journal-title":"Biomedicines"},{"key":"4422_CR59","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.redox.2022.102547","volume":"59","author":"Q Guo","year":"2023","unstructured":"Guo Q, Kawahata I, Cheng A, Wang H, Jia W, Yoshino H, Fukunaga K (2023) Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons. Redox Biol 59:102547. https:\/\/doi.org\/10.1016\/j.redox.2022.102547","journal-title":"Redox Biol"},{"key":"4422_CR60","doi-asserted-by":"publisher","unstructured":"Jin R, Hao JA-O, Yi Y, Yin D, Hua Y, Li X, Bao H, Han X, Egilmez NA-O, Sauter ER, Li B (2021 021) dietary fats high in Linoleic acids impair antitumor T-cell responses by inducing E-FABP-Mediated mitochondrial dysfunction. Cancer Res 81(20):5296\u20135310https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0757","DOI":"10.1158\/0008-5472.CAN-21-0757"},{"issue":"2","key":"4422_CR61","doi-asserted-by":"publisher","first-page":"e000501","DOI":"10.1136\/jitc-2019-000501","volume":"8","author":"F Liu","year":"2020","unstructured":"Liu F, Liu W, Zhou S, Yang C, Tian M, Jia G, Wang H, Zhu B, Feng M, Lu Y, Qiao T, Wang X, Cao W, Wang X, Shi Y, Wu DA-O (2020) Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma. J Immunother Cancer 8(2):e000501. https:\/\/doi.org\/10.1136\/jitc-2019-000501","journal-title":"J Immunother Cancer"},{"key":"4422_CR62","doi-asserted-by":"publisher","first-page":"e8118","DOI":"10.7554\/eLife.81184","volume":"12","author":"M Farrell","year":"2023","unstructured":"Farrell M, Fairfield HA-O, Karam M, D\u2019Amico A, Murphy CS, Falank C, Pistofidi RS, Cao A, Marinac CR, Dragon JA, McGuinness L, Gartner CG, Iorio RD, Jachimowicz E, DeMambro V, Vary C, Reagan MA-O (2023) Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling. Elife 12:e8118. https:\/\/doi.org\/10.7554\/eLife.81184","journal-title":"Elife"},{"issue":"4","key":"4422_CR63","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","volume":"82","author":"X Yang","year":"2025","unstructured":"Yang X, Deng B, Zhao W, Guo Y, Wan Y, Wu Z, Su S, Gu J, Hu X, Feng W, Hu C, Li J, Xu Y, Huang X, Lin Y (2025) FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity. J Hepatol 82(4):676\u2013689. https:\/\/doi.org\/10.1016\/j.jhep.2024.09.029","journal-title":"J Hepatol"},{"key":"4422_CR64","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41586-024-08071-y","volume":"635","author":"SM Hwang","year":"2024","unstructured":"Hwang SM, Awasthi D, Jeong J, Sandoval TA, Chae CS, Ramos Y, Tan C, Marin Falco M, Salvagno C, Emmanuelli A, McBain IT, Mishra B, Ivashkiv LB, Zamarin D, Cantillo E, Chapman-Davis E, Holcomb K, Morales DK, Yu X, Rodriguez PC, Conejo-Garcia JR, Kaczocha M, Vaharautio A, Song M, Cubillos-Ruiz JR (2024) Transgelin 2 guards T cell lipid metabolism and antitumour function. Nature 635:1010\u20131018. https:\/\/doi.org\/10.1038\/s41586-024-08071-y","journal-title":"Nature"},{"issue":"8","key":"4422_CR65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s12012-021-09653-2","volume":"21","author":"S Gao","year":"2021","unstructured":"Gao S, Li G, Shao Y, Wei Z, Huang S, Qi F, Jiao Y, Li Y, Zhang C, Du J (2021) FABP5 deficiency impairs mitochondrial function and aggravates pathological cardiac remodeling and dysfunction. Cardiovasc Toxicol 21(8):619\u2013629. https:\/\/doi.org\/10.1007\/s12012-021-09653-2","journal-title":"Cardiovasc Toxicol"},{"issue":"3","key":"4422_CR66","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1021\/acs.molpharmaceut.9b01131","volume":"17","author":"YL Low","year":"2020","unstructured":"Low YL, Jin L, Morris ER, Pan YA-O, Nicolazzo JA-O (2020) Pioglitazone increases Blood-Brain barrier expression of fatty acid-Binding protein 5 and docosahexaenoic acid trafficking into the brain. Mol Pharm 17(3):873\u2013884. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b01131","journal-title":"Mol Pharm"},{"key":"4422_CR67","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/stem.1124","volume":"30","author":"M Matsumata","year":"2012","unstructured":"Matsumata M, Sakayori N, Maekawa M, Owada Y, Yoshikawa T, Osumi N (2012) The effects of Fabp7 and Fabp5 on postnatal hippocampal neurogenesis in the mouse. Stem Cells 30:1532\u20131543. https:\/\/doi.org\/10.1002\/stem.1124","journal-title":"Stem Cells"},{"key":"4422_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jnc.14249","volume":"144","author":"Y Pan","year":"2018","unstructured":"Pan Y, Choy KHC, Marriott PJ, Chai SY, Scanlon MJ, Porter CJH, Short JL, Nicolazzo JA (2018) Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP\/PS1 mice to cognitive deficits from low omega-3 fatty acid diets. J Neurochem 144:81\u201392. https:\/\/doi.org\/10.1111\/jnc.14249","journal-title":"J Neurochem"},{"key":"4422_CR69","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/jnc.14342","volume":"146","author":"Y Pan","year":"2018","unstructured":"Pan Y, Morris ER, Scanlon MJ, Marriott PJ, Porter CJH, Nicolazzo JA (2018) Dietary docosahexaenoic acid supplementation enhances expression of fatty acid-binding protein 5 at the blood-brain barrier and brain docosahexaenoic acid levels. J Neurochem 146:186\u2013197. https:\/\/doi.org\/10.1111\/jnc.14342","journal-title":"J Neurochem"},{"key":"4422_CR70","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jnr.24728","volume":"99","author":"K Yamagata","year":"2021","unstructured":"Yamagata K (2021) Dietary docosahexaenoic acid inhibits neurodegeneration and prevents stroke. J Neurosci Res 99:561\u2013572. https:\/\/doi.org\/10.1002\/jnr.24728","journal-title":"J Neurosci Res"},{"issue":"22","key":"4422_CR71","doi-asserted-by":"publisher","first-page":"e2300758","DOI":"10.1002\/advs.202300758","volume":"10","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, Liu H, Zhang H, Han Y, Yuan J, Wang T, Gao Y, Li Z (2023) Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson\u2019s disease. Adv Sci 10(22):e2300758. https:\/\/doi.org\/10.1002\/advs.202300758","journal-title":"Adv Sci"},{"issue":"10","key":"4422_CR72","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1007\/s11095-015-1764-5","volume":"32","author":"GS Lee","year":"2015","unstructured":"Lee GS, Kappler K, Porter CJ, Scanlon MJ, Nicolazzo JA (2015) Fatty acid binding proteins expressed at the human Blood-Brain barrier bind drugs in an Isoform-Specific manner. Pharm Res 32(10):3432\u20133446. https:\/\/doi.org\/10.1007\/s11095-015-1764-5","journal-title":"Pharm Res"},{"issue":"5","key":"4422_CR73","doi-asserted-by":"publisher","first-page":"112342","DOI":"10.1016\/j.isci.2025.112342","volume":"28","author":"S Oubraim","year":"2025","unstructured":"Oubraim S, Fauzan M, Studholme K, Gordon C, Glaser ST, Shen RY, Ojima I, Kaczocha M, Haj-Dahmane S (2025) Astrocytic FABP5 mediates retrograde endocannabinoid transport at central synapses. iScience 28(5):112342. https:\/\/doi.org\/10.1016\/j.isci.2025.112342","journal-title":"iScience"},{"issue":"12","key":"4422_CR74","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/pmic.200400848","volume":"4","author":"M Basso","year":"2024","unstructured":"Basso M, Giraudo S, Fau - Corpillo D, Corpillo D, Fau - Bergamasco B, Bergamasco B, Fau - Lopiano L, Lopiano L, Fau - Fasano M, Fasano M (2024) Proteome analysis of human substantia Nigra in Parkinson\u2019s disease. Proteomics 4(12):3943\u20133952. https:\/\/doi.org\/10.1002\/pmic.200400848","journal-title":"Proteomics"},{"key":"4422_CR75","doi-asserted-by":"publisher","unstructured":"Teunissen CE, Veerhuis R, De Fau - J, De Vente J, Fau - Verhey FRJ, Verhey Fr Fau - Vreeling, Vreeling F, Fau F, van Boxtel MPJ Boxtel Mp Fau - Glatz JFC, Glatz Jf Fau -, Pelsers MAL, Pelsers MA (2011) Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases. European journal of neurology 18(6):865-871. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03273.x","DOI":"10.1111\/j.1468-1331.2010.03273.x"},{"issue":"6739","key":"4422_CR76","doi-asserted-by":"publisher","first-page":"eadm9805","DOI":"10.1126\/science.adm9805","volume":"387","author":"NA-O Koundouros","year":"2025","unstructured":"Koundouros NA-O, Nagiec MA-O, Bullen NA-O, Noch EA-O, Burgos-Barragan GA-O, Li ZA-O, He LA-O, Cho S, Parang BA-O, Leone D, Andreopoulou E, Blenis JA-O (2025) Direct sensing of dietary \u03c9-6 Linoleic acid through FABP5-mTORC1 signaling. Sci (New York NY) 387(6739):eadm9805. https:\/\/doi.org\/10.1126\/science.adm9805","journal-title":"Sci (New York NY)"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04422-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04422-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04422-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T16:44:41Z","timestamp":1750697081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04422-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4422"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04422-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Review Committee of Jiangsu University (Permit No. SCXK 2023-0017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"177"}}